BD Announces Agreement to Sell Clontech to Takara

BD (Becton, Dickinson and Company) today announced that it has signed an agreement to sell the Company's Clontech operation, a unit of BD Biosciences, to Takara Bio Inc., Otsu, Japan, subject to regulatory approvals. BD's plan to sell Clontech was previously announced on October 4, 2004.

BD Announces Agreement to Sell Clontech

BioBOOM Op/Ed: Rumor has it for only $60 million!!?? Not a well managed deal for a known brand and "one time" life science contender valued at upwards of $200 mil. Terrible return to share holders. Do we hear a toilet flushing?

No comments:

Blog Archive